InBody Co.,Ltd (041830.KQ)

KRW 21950.0

(-1.13%)

Eps Summary of InBody Co.,Ltd

InBody Co.,Ltd's latest annual eps in 2023 was 2819.01 KRW , up 8.6% from previous year.
InBody Co.,Ltd's latest quarterly eps in 2024 Q2 was 637.24 KRW , down -5.64% from previous quarter.
InBody Co.,Ltd reported an annual eps of 2595.83 KRW in 2022, down -0.64% from previous year.
InBody Co.,Ltd reported an annual eps of 2612.57 KRW in 2021, up 95.64% from previous year.
InBody Co.,Ltd reported a quarterly eps of 637.24 KRW for 2024 Q2, down -5.64% from previous quarter.
InBody Co.,Ltd reported a quarterly eps of 540.83 KRW for 2023 Q2, down -31.92% from previous quarter.

Annual Eps Chart of InBody Co.,Ltd (2023 - 2012)

Historical Annual Eps of InBody Co.,Ltd (2023 - 2012)

Year	Eps	Eps Growth
2023	2819.01 KRW	8.6%
2022	2595.83 KRW	-0.64%
2021	2612.57 KRW	95.64%
2020	1335.40 KRW	-12.82%
2019	1531.73 KRW	4.99%
2018	1458.98 KRW	2.01%
2017	1430.26 KRW	14.62%
2016	1247.88 KRW	-1.87%
2015	1271.68 KRW	95.04%
2014	652.00 KRW	43.3%
2013	455.00 KRW	9.64%
2012	415.00 KRW	0.0%

Year	Eps	Eps Growth
2024 Q1	675.31 KRW	20.9%
2024 Q2	637.24 KRW	-5.64%
2023 Q2	540.83 KRW	-31.92%
2023 Q1	794.37 KRW	74.51%
2023 FY	- KRW	8.6%
2023 Q3	925.23 KRW	71.08%
2023 Q4	558.57 KRW	-39.63%
2022 Q3	706.61 KRW	6.67%
2022 Q1	771.60 KRW	17.16%
2022 FY	- KRW	-0.64%
2022 Q4	455.19 KRW	-35.58%
2022 Q2	662.44 KRW	-14.15%
2021 Q4	658.56 KRW	21.35%
2021 Q1	771.23 KRW	60.08%
2021 FY	- KRW	95.64%
2021 Q2	640.09 KRW	-17.0%
2021 Q3	542.68 KRW	-15.22%
2020 Q1	371.33 KRW	52.03%
2020 Q3	452.58 KRW	1373.24%
2020 Q4	481.79 KRW	6.45%
2020 FY	- KRW	-12.82%
2020 Q2	30.72 KRW	-91.73%
2019 Q4	244.24 KRW	-34.54%
2019 Q3	373.12 KRW	-27.05%
2019 FY	- KRW	4.99%
2019 Q1	402.52 KRW	36.22%
2019 Q2	511.50 KRW	27.07%
2018 Q1	272.73 KRW	-41.01%
2018 Q3	444.00 KRW	-0.62%
2018 Q2	446.75 KRW	63.81%
2018 FY	- KRW	2.01%
2018 Q4	295.50 KRW	-33.45%
2017 FY	- KRW	14.62%
2017 Q4	462.37 KRW	8.28%
2017 Q2	363.38 KRW	103.3%
2017 Q1	178.74 KRW	-44.83%
2017 Q3	427.00 KRW	17.51%
2016 Q4	323.98 KRW	42.1%
2016 FY	- KRW	-1.87%
2016 Q3	228.00 KRW	-33.18%
2016 Q2	341.19 KRW	-3.88%
2016 Q1	354.97 KRW	13.04%
2015 Q4	314.01 KRW	-21.1%
2015 FY	- KRW	95.04%
2015 Q1	279.00 KRW	394.24%
2015 Q2	280.85 KRW	0.66%
2015 Q3	398.00 KRW	41.71%
2014 Q1	248.03 KRW	221.7%
2014 Q2	184.04 KRW	-25.8%
2014 Q3	164.00 KRW	-10.89%
2014 Q4	56.45 KRW	-65.58%
2014 FY	- KRW	43.3%
2013 Q1	184.16 KRW	519.86%
2013 Q4	77.10 KRW	-26.57%
2013 FY	- KRW	9.64%
2013 Q2	88.00 KRW	-52.22%
2013 Q3	105.00 KRW	19.32%
2012 Q3	92.00 KRW	0.0%
2012 Q4	29.71 KRW	-67.71%
2012 FY	- KRW	0.0%

Peer Eps Comparison of InBody Co.,Ltd

Name	Eps	Eps Difference
Osang Healthcare Co.,Ltd	9148.00 KRW	69.184%
Curexo Inc.	-120.00 KRW	2449.175%
Seegene, Inc.	14.19 KRW	-19766.173%
i-SENS, Inc.	134.89 KRW	-1989.858%
Ray Co., Ltd.	-140.25 KRW	2109.989%
Gencurix Inc.	-1629.25 KRW	273.025%
Sugentech Inc.	-1090.00 KRW	358.625%
L&C Bio Co., Ltd	2096.33 KRW	-34.474%